OnKure Therapeutics, Inc. (OKUR) Financials

OKUR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 179.4 million 7.2 million
March 31, 2026 198.7 million 14.3 million
Dec. 31, 2025 62.1 million 5.9 million
Sept. 30, 2025 72.8 million 6.4 million

OKUR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -10.4 million 3.0 million
March 31, 2026 -12.9 million 2.8 million
Dec. 31, 2025 -11.5 million 3.0 million
Sept. 30, 2025 -13.0 million 3.0 million

OKUR Net Income

No data available :(

OKUR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 176.4 million - 926000
March 31, 2026 192.1 million - 409000
Dec. 31, 2025 59.1 million - 549000
Sept. 30, 2025 70.3 million - 687000

OKUR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 49.9 million
March 31, 2026 13.7 million
Dec. 31, 2025 13.5 million
Sept. 30, 2025 13.5 million

OKUR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3000 12.6 million 4.3 million -
March 31, 2026 5000 11.7 million 3.9 million -
Dec. 31, 2025 9000 10.7 million 3.4 million -
Sept. 30, 2025 6000 11.9 million 3.6 million -

OKUR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 203000
Dec. 31, 2025 - 202000
Sept. 30, 2025 - -

OKUR

Price: $3.94

52 week price:
1.91
5.38

Earnings Per Share: -3.11 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 166.0 million

Links: